Page last updated: 2024-10-30

losartan and Astrocytosis

losartan has been researched along with Astrocytosis in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
" We test such interactions in the brain and cerebral vessels of TGF mice by measuring cerebrovascular reactivity, levels of protein markers of vascular fibrosis, nitric oxide synthase activity, astrogliosis, and mnemonic performance in mice treated (6 months) with the AT1R blocker losartan (10 mg/kg per day) or the angiotensin converting enzyme inhibitor enalapril (3 mg/kg per day)."3.88Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways. ( Hamel, E; Imboden, H; Lecrux, C; Nicolakakis, N; Ongali, B; Tong, XK, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ongali, B1
Nicolakakis, N1
Tong, XK1
Lecrux, C1
Imboden, H1
Hamel, E1

Other Studies

1 other study available for losartan and Astrocytosis

ArticleYear
Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:5

    Topics: Animals; Brain; Enalapril; Female; Fibrosis; Gliosis; Losartan; Male; Mice; Mice, Transgenic; Recept

2018